Synapse - Radiation Oncology, Department of

Search Within

Radiation Oncology, Department of

Results (5284)

Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis

Meeting Abstract

Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Impact of clonal hematopoiesis on tumor control following radiation therapy

Meeting Abstract

Tao, J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM)

Meeting Abstract

Skakodub, A.; Tringale, K. R.; Walch, H. S.; Vasudevan, H.; Eichholz, J.; Kelly, D. W.; Moss, N. S.; Yu, K. K. H.; Li, B. T.; Mueller, B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer

Meeting Abstract

Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A randomized phase III study assessing the efficacy of liquid biopsy in early diagnosis of recurrence and second malignancies in lung cancer survivors

Meeting Abstract

Raoof, S.; Gomez, D. R.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients with muscle-invasive bladder cancer who are cisplatin-ineligible

Meeting Abstract

Petrylak, D. P.; Flaig, T. W.; Mar, N.; Gourdin, T. S.; Srinivas, S.; Rosenberg, J. E.; Guseva, M.; Yu, Y.; Narayanan, S.; Hoimes, C. J.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)-A randomized phase 3, double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation

Meeting Abstract

Niazi, T.; McBride, S. M.; Williams, S.; Davis, I. D.; Stockler, M. R.; Martin, A. J.; Bracken, K.; Roncolato, F.; Horvath, L.; Sengupta, S.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Quantification of methylation-specific cardiomyocyte cell-free DNA as an early marker of cardiotoxicity in patients with breast cancer receiving anthracyclines and trastuzumab

Meeting Abstract

Moore, Z. R.; Yu, A. F.; Liu, J.; Dang, C. T.; Oeffinger, K. C.; Steingart, R.; Schmitt, A.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001)

Meeting Abstract

Mansfield, A. S.; Goodrich, A.; Foster, N. R.; Ernani, V.; Forde, P. M.; Villaruz, L. C.; Raghav, K. P. S.; Romesser, P. B.; Garbacz, K.; Cao, L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery

Meeting Abstract

Ma, J.; del Balzo, L.; Khaleel, S. S.; Flynn, J.; Zhang, Z.; Voss, M. H.; Freeman, B.; Hakimi, A. A.; Lee, C. H.; Eichholz, J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save